Which is the best combination of TACE and Sorafenib for advanced hepatocellular carcinoma treatment? A systematic review and network meta-analysis
Pharmacological Research(2018)
Abstract
•Combination therapy of TACE and Sorafenib were commonly used; but the best choice of chemotherapy in TACE has not been identified.•Combination group with HCPT had the advantage of long-term efficacy, and Adriamycin showed short-term efficacy.•The safety of MMC and 5-Fu were suboptimal, and Adriamycin and HCPT were safer than Platinum.•The TACE(HCPT + THP) +Sorafenib and TACE (HCPT + EPI) +Sorafenib arms had significantly different efficacy rates.•Combination therapy with HCPT + THP/EPI in TACE and Sorafenib may be used as a first-line treatment in advanced HCC patients.
MoreTranslated text
Key words
Transarterial chemoembolization,TACE,Sorafenib,Advanced hepatocellular carcinoma,Network meta-analysis
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined